Publication:
Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing

dc.contributor.authorGalayanee Doungchaweeen_US
dc.contributor.authorUraiwan Kositanonten_US
dc.contributor.authorAnuchai Niwetpathomwaten_US
dc.contributor.authorTasanee Inwisaien_US
dc.contributor.authorPlyyonk Sagarasaeraneeen_US
dc.contributor.authorDavid A. Haakeen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherVA Medical Centeren_US
dc.contributor.otherDavid Geffen School of Medicine at UCLAen_US
dc.date.accessioned2018-07-12T02:19:39Z
dc.date.available2018-07-12T02:19:39Z
dc.date.issued2008-03-01en_US
dc.description.abstractThere is an urgent need for the development of serodiagnostic approaches with improved sensitivity for patients with acute leptospirosis. Immunoblots were performed on 188 sera collected from 74 patients with laboratory-confirmed early leptospiral infection to detect immunoglobulin M (IgM) antibodies to antigens pooled from 10 leptospiral strains prevalent in Thailand. Sera from patients with other febrile diseases served as controls. IgM reactivity to seven distinct antigens, with apparent molecular masses of 14 to 18, 19 to 23, 24 to 30, 32, 35/36, 37, and 41/42 kDa, was observed. The low-molecular-mass 14- to 18-kDa band was the most frequently detected antigen, being recognized in sera from 82.4% of patients during the first 3 days after the onset of symptoms. We evaluated the accuracy of the IgM immunoblot (IgM-IB) test by using reactivity to the 14- to 18-kDa band and/or at least two bands among the 19- to 23-, 24- to 30-, 32-, 35/36-, 37-, and 41/42-kDa antigens as the diagnostic criterion. The sensitivities of the IgM-IB test and the microscopic agglutination test (MAT) were 88.2% and 2.0%, respectively, with sera from patients 1 to 3 days after the onset of symptoms. In contrast, the IgM-IB test was positive with only 2/48 (4.2%) sera from patients with other febrile illnesses. The high sensitivity and specificity of the IgM-IB test for acute leptospirosis would provide greatly improved diagnostic accuracy for identification of patients who would benefit from early antibiotic intervention. In addition, the antigens identified by the IgM-IB test may serve as components of a rapid, accurate, point-of-care diagnostic test for early leptospirosis. Copyright © 2008, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.citationClinical and Vaccine Immunology. Vol.15, No.3 (2008), 492-498en_US
dc.identifier.doi10.1128/CVI.00152-07en_US
dc.identifier.issn1556679Xen_US
dc.identifier.issn15566811en_US
dc.identifier.other2-s2.0-42049114285en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18966
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=42049114285&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleEarly diagnosis of leptospirosis by immunoglobulin M immunoblot testingen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=42049114285&origin=inwarden_US

Files

Collections